Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

149.51 -0.16 (-0.11%)

Streaming Delayed Price Updated: 3:37 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

42 43 Next >

Leading And Lagging Sectors For February 4, 2025 ↗

February 04, 2025

Via Benzinga

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

Communications Have More To Say ↗

February 03, 2025

Last week was certainly memorable, and it looks like this week is off to a similar start.

Via Talk Markets

Topics Stocks / Equities

Leading And Lagging Sectors For February 3, 2025 ↗

February 03, 2025

Via Benzinga

Trump's 25% Tariffs Could Slaughter Canada, Mexico Economies, Hit US Auto Industry, Analysts Warn ↗

January 31, 2025

Trade war between US, Canada, and Mexico could cause severe economic damage, raise prices, and disrupt supply chains in key industries.

Via Benzinga

Topics Government World Trade

AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens ↗

January 31, 2025

The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025.

Via Stocktwits

Leading And Lagging Sectors For January 31, 2025 ↗

January 31, 2025

Via Benzinga

How We Can Trade On GDP ↗

January 30, 2025

What we got today, of course, was advance GPD, which is the earliest measure and also the most likely to provoke a reaction in stocks.

Via Talk Markets

Topics Commodities Futures Stocks / Equities

Leading And Lagging Sectors For January 30, 2025 ↗

January 30, 2025

Via Benzinga

Leading And Lagging Sectors For January 29, 2025 ↗

January 29, 2025

Via Benzinga

Does China AI Threaten US Tech Dominance? ↗

January 28, 2025

Anxiety about the competitive threat from Chinese artificial intelligence lab DeepSeek triggered a sharp selloff in US equities on Monday, with the worst of the decline centered in tech.

Via Talk Markets

Topics Artificial Intelligence ETFs

Leading And Lagging Sectors For January 28, 2025 ↗

January 28, 2025

Via Benzinga

Biotech And Healthcare Stocks Poised For Gains Ahead ↗

January 27, 2025

The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech.

Via Talk Markets

Topics ETFs Stocks / Equities

Leading And Lagging Sectors For January 27, 2025 ↗

January 27, 2025

Via Benzinga

Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High ↗

January 24, 2025

The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats.

Via Stocktwits

Leading And Lagging Sectors For January 24, 2025 ↗

January 24, 2025

Via Benzinga

Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon ↗

January 23, 2025

The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected.

Via Stocktwits

Leading And Lagging Sectors For January 23, 2025 ↗

January 23, 2025

Via Benzinga

J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient ↗

January 22, 2025

During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually.

Via Stocktwits

Topics Earnings

Leading And Lagging Sectors For January 22, 2025 ↗

January 22, 2025

Via Benzinga

Small Caps Soar, Apple Slips, Treasury Yields Fall On Trump Day 2: What's Driving Markets Tuesday? ↗

January 21, 2025

Wall Street saw a strong preference for small and mid-cap equities, with the Russell 2000 index leading the market as investors bet on more domestic-friendly policies following Donald Trump's...

Via Benzinga

Topics Government

Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump ↗

January 21, 2025

In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older.

Via Stocktwits

Leading And Lagging Sectors For January 21, 2025 ↗

January 21, 2025

Via Benzinga

Leading And Lagging Sectors For January 20, 2025 ↗

January 20, 2025

Via Benzinga

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Via Talk Markets

Topics ETFs Stocks / Equities

Wall Street Roars Ahead Of Trump's Inauguration, Intel Rallies, Bitcoin Tops $105,000: What's Driving Markets Friday? ↗

January 17, 2025

Risk appetite surged on Wall Street at the end of the week, with investors ramping up stock purchases ahead of Monday's market closure for Martin Luther King Day, which is also when Donald Trump will...

Via Benzinga

Topics Government

Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What's Driving Markets Thursday? ↗

January 16, 2025

Wall Street paused for a breather on Thursday, following Wednesday's big rally sparked by a softer-than-predicted December inflation report that fueled speculation on the Federal Reserve delivering...

Via Benzinga

Topics Economy

UnitedHealth's Q4 Revenue Miss Depresses Stock Price And Retail Sentiment Alike ↗

January 16, 2025

The company's full-year medical loss ratio, a key metric tracking the percentage of premiums paid out for medical expenses, rose to 85.5% from 83.2% in 2023.

Via Stocktwits

Leading And Lagging Sectors For January 16, 2025 ↗

January 16, 2025

Via Benzinga

Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In ↗

January 15, 2025

Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures.

Via Stocktwits

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.